Cargando…
Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review
BACKGROUND: The use of ketamine for depression has increased rapidly in the past decades. Ketamine is often prescribed as an add-on to other drugs used in psychiatric patients, but clear information on drug-drug interactions is lacking. With this review, we aim to provide an overview of the pharmaco...
Autores principales: | Veraart, Jolien K E, Smith-Apeldoorn, Sanne Y, Bakker, Iris M, Visser, Berber A E, Kamphuis, Jeanine, Schoevers, Robert A, Touw, Daan J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538895/ https://www.ncbi.nlm.nih.gov/pubmed/34170315 http://dx.doi.org/10.1093/ijnp/pyab039 |
Ejemplares similares
-
Oral S-ketamine effective after deep brain stimulation in severe treatment-resistant depression and extensive comorbidities
por: Veraart, Jolien K E, et al.
Publicado: (2021) -
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
por: Smith-Apeldoorn, Sanne Y., et al.
Publicado: (2019) -
Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
por: Smith-Apeldoorn, Sanne Y., et al.
Publicado: (2020) -
The antidepressant effect and safety of non-intranasal esketamine: A systematic review
por: Smith-Apeldoorn, Sanne Y, et al.
Publicado: (2022) -
Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
por: Smith-Apeldoorn, Sanne Y., et al.
Publicado: (2021)